State Street’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Hold |
133,333
| – | – | ﹤0.01% | 3861 |
|
|
2025
Q1 | $159K | Hold |
133,333
| – | – | ﹤0.01% | 3877 |
|
|
2024
Q4 | $217K | Buy |
133,333
+21,500
| +19% | +$35K | ﹤0.01% | 3832 |
|
|
2024
Q3 | $427K | Sell |
111,833
-18,700
| -14% | -$71.4K | ﹤0.01% | 3624 |
|
|
2024
Q2 | $382K | Sell |
130,533
-426,787
| -77% | -$1.25M | ﹤0.01% | 3621 |
|
|
2024
Q1 | $2.21M | Buy |
557,320
+5,288
| +1% | +$20.9K | ﹤0.01% | 3247 |
|
|
2023
Q4 | $2.74M | Buy |
552,032
+47,091
| +9% | +$234K | ﹤0.01% | 3203 |
|
|
2023
Q3 | $2.55M | Buy |
504,941
+47,966
| +10% | +$242K | ﹤0.01% | 3227 |
|
|
2023
Q2 | $2.3M | Buy |
456,975
+354,442
| +346% | +$1.78M | ﹤0.01% | 3349 |
|
|
2023
Q1 | $631K | Buy |
102,533
+7,500
| +8% | +$46.1K | ﹤0.01% | 3666 |
|
|
2022
Q4 | $1.25M | Buy |
95,033
+13,800
| +17% | +$182K | ﹤0.01% | 3509 |
|
|
2022
Q3 | $241K | Hold |
81,233
| – | – | ﹤0.01% | 4053 |
|
|
2022
Q2 | $297K | Buy |
81,233
+4,700
| +6% | +$17.2K | ﹤0.01% | 4033 |
|
|
2022
Q1 | $474K | Buy |
76,533
+4,057
| +6% | +$25.1K | ﹤0.01% | 4069 |
|
|
2021
Q4 | $587K | Buy |
72,476
+9,500
| +15% | +$76.9K | ﹤0.01% | 3960 |
|
|
2021
Q3 | $938K | Buy |
62,976
+3,800
| +6% | +$56.6K | ﹤0.01% | 3795 |
|
|
2021
Q2 | $743K | Buy |
+59,176
| New | +$743K | ﹤0.01% | 3723 |
|
|
2019
Q1 | – | Sell |
-676
| Closed | -$4K | – | 3753 |
|
|
2018
Q4 | $4K | Hold |
676
| – | – | ﹤0.01% | 3754 |
|
|
2018
Q3 | $10K | Sell |
676
-106
| -14% | -$1.57K | ﹤0.01% | 3757 |
|
|
2018
Q2 | $17K | Sell |
782
-16,582
| -95% | -$360K | ﹤0.01% | 3743 |
|
|
2018
Q1 | $409K | Buy |
17,364
+2,436
| +16% | +$57.4K | ﹤0.01% | 3462 |
|
|
2017
Q4 | $2.8M | Buy |
14,928
+821
| +6% | +$154K | ﹤0.01% | 3059 |
|
|
2017
Q3 | $3.03M | Buy |
14,107
+239
| +2% | +$51.3K | ﹤0.01% | 3028 |
|
|
2017
Q2 | $2.85M | Buy |
13,868
+1,946
| +16% | +$400K | ﹤0.01% | 2991 |
|
|
2017
Q1 | $2.17M | Buy |
11,922
+1,907
| +19% | +$347K | ﹤0.01% | 3057 |
|
|
2016
Q4 | $2.51M | Buy |
10,015
+543
| +6% | +$136K | ﹤0.01% | 3015 |
|
|
2016
Q3 | $1.97M | Buy |
9,472
+1,562
| +20% | +$325K | ﹤0.01% | 2970 |
|
|
2016
Q2 | $1.6M | Buy |
7,910
+3,014
| +62% | +$610K | ﹤0.01% | 3112 |
|
|
2016
Q1 | $897K | Buy |
4,896
+1,535
| +46% | +$281K | ﹤0.01% | 3242 |
|
|
2015
Q4 | $841K | Buy |
+3,361
| New | +$841K | ﹤0.01% | 3246 |
|